Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Giuseppe Pietrantuono
Complete Molecular Response Induced by Nilotinib in a Patient Previously Treated With Imatinib, Nilotinib and Dasatinib
Clinical Management Issues
Medicine
Accounting
Management
Business
Related publications
Evaluation of Nilotinib in Advanced GIST Previously Treated With Imatinib and Sunitinib
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Therapeutic Drug Monitoring of Imatinib, Nilotinib, and Dasatinib for Patients With Chronic Myeloid Leukemia
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Major Molecular Response Induced by Nilotinib as First Line Treatment in a LMC Patient With Intermediate Sokal Risk
Clinical Management Issues
Medicine
Accounting
Management
Business
Response to Imatinib in Villonodular Pigmented Synovitis (PVNS) Resistant to Nilotinib
Clinical Sarcoma Research
Oncology
Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Long-Term Molecular and Cytogenetic Response and Survival Outcomes With Imatinib 400 Mg, Imatinib 800 Mg, Dasatinib, and Nilotinib in Patients With Chronic-Phase Chronic Myeloid Leukaemia: Retrospective Analysis of Patient Data From Five Clinical Trials
The Lancet Haematology
Hematology
Pancreatic Enzyme Elevation in Chronic Myeloid Leukemia Patients Treated With Nilotinib After Imatinib Failure
Haematologica
Hematology
Nilotinib Übertrifft Imatinib in Der First-Line Weiterhin
Info Onkologie
The Third-Time Chronic Myeloid Leukemia in Lymphoblastic Crisis With ABL1 Kinase Mutation Induced by Decitabine, Dexamethason Combined With Nilotinib and Dasatinib
Journal of Translational Internal Medicine
